Canada Markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1450-0.0050 (-3.33%)
At close: 02:40PM EST
Full screen
Previous Close0.1500
Open0.1500
Bid0.1450 x 0
Ask0.1600 x 0
Day's Range0.1400 - 0.1500
52 Week Range0.1100 - 0.2400
Volume71,000
Avg. Volume52,851
Market Cap16.648M
Beta (5Y Monthly)0.34
PE Ratio (TTM)N/A
EPS (TTM)-0.0350
Earnings DateMar. 23, 2022 - Mar. 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Wound Care Commercialization to be a Key Company Focus in 2022

    New video blog series part of 2022 commitment to increase and broaden communication to investorsWINNIPEG, Manitoba, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Kane Biotech CEO, Marc Edwards sees its rich 20-year history of biofilm research and product development as a real strategic advantage in the wound care and surgical markets. “Biofilms in wound care have been an increasing topic of discussion amongst industry professionals for less than a decade but have now grown to be recognized as one of the big

  • GlobeNewswire

    Kane Biotech Announces Third Quarter 2021 Financial Results

    WINNIPEG, Manitoba, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced their third quarter 2021 financial results. Third Quarter Financial Highlights Revenue from product sales in the three months ended September 30, 2021 was $438,016, an increase of 53% compared to $286,934 in the three months ended September 30, 2020. This increase is due mainly to sales attributable to a new major pet retail customer and the financi

  • GlobeNewswire

    Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 – Conference Call to Follow

    WINNIPEG, Manitoba, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will announce its third quarter 2021 financial results after market close on Thursday, November 16, 2021. Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and d